Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
JNJ News
Unusual total active option classes on open include: Energy Fuels (UUUU), Maplebear Inc (CART), Eli Lilly (LLY), Dollar General (DG), American Express (AXP), CV...
Johnson & Johnson JNJ reported upbeat first-quarter results on Wednesday. Here are some key analyst takeaways. Goldman Sachs On Johnson & Johnson Analyst Asa...
Morgan Stanley raised the firm’s price target on Johnson & Johnson to $169 from $164 and keeps an Equal Weight rating on the shares after the company posted a Q...
Analyst ratings
54%
of 24 ratingsMore JNJ News
Bernstein analyst Lee Hambright maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) today and set a price target of $159.00. Lee Hambright’s...
Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), boosting the price target to $169.00. Terence Fl...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a price target of $...
Asad Haider, an analyst from Goldman Sachs, maintained the Buy rating on Johnson & Johnson (JNJ – Research Report). The associated price target remains the same...
Johnson & Johnson ((JNJ)) has held its Q1 earnings call. Read on for the main highlights of the call. The recent earnings call for Johnson & Johnson painted a...
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Josh Jennings from TD Cowen main...
Johnson & Johnson (JNJ) beat Wall Street expectations in its first-quarter earnings report and raised its 2025 sales forecast by $700 million, even though sales...